OAM
MRNA icon

Ostrum Asset Management’s Moderna MRNA Stock Holding History

Ostrum Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-779
Closed -$22.1K – 611
2025
Q1 		$22.1K Sell
779
-21
-3% -$745 ﹤0.01% 638
2024
Q4 		$33.3K Sell
800
-34
-4% -$1.63K ﹤0.01% 624
2024
Q3 		$55.7K Buy
834
+11
+1% +$1.01K ﹤0.01% 609
2024
Q2 		$97.7K Sell
823
-65
-7% -$8.23K 0.01% 590
2024
Q1 		$94.6K Hold
888
– – 0.01% 606
2023
Q4 		$88.3K Buy
888
+4
+0.5% +$336 0.01% 596
2023
Q3 		$91.3K Sell
884
-1,314
-60% -$147K 0.01% 630
2023
Q2 		$267K Buy
2,198
+9
+0.4% +$1.2K 0.02% 506
2023
Q1 		$336K Buy
+2,189
New +$361K 0.03% 485

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ostrum Asset Management's MRNA Position: Q2 2025 in Review

Ostrum Asset Management sold out of Moderna (MRNA) in Q2 2025, closing a stake of 779 shares — an estimated $22.1K sold.

Ostrum Asset Management first reported a position in MRNA in Q1 2023 and held it in 9 quarters. The position peaked at $336K in Q1 2023. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Ostrum Asset Management reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Ostrum Asset Management sold 779 Moderna shares in Q2 2025, an estimated $22.1K.
  • Ostrum Asset Management first reported a position in Moderna in Q1 2023 and held it in 9 quarters.
  • Ostrum Asset Management's Moderna position peaked at $336K in Q1 2023.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Ostrum Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.